Ledermycin

Demeclocycline Hydrochloride, the active ingredient in Ledermycin, is a tetracycline antibiotic presented as an oral dosage form for systemic use. It is employed to manage bacterial skin conditions such as acne vulgaris and rosacea, and it may be prescribed for the syndrome of inappropriate antidiuretic hormone secretion (SIADH) when other therapies are unsuitable.

GNH USA supplies Ledermycin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets.

Ledermycin is a tetracycline antibiotic used to treat bacterial skin disorders and certain endocrine disturbances. - Acne vulgaris: reduces inflammatory lesions and bacterial colonisation on the skin. - Rosacea: diminishes papules, pustules and erythema associated with the condition. - Syndrome of inappropriate antidiuretic hormone secretion (SIADH): helps correct hyponatraemia by antagonising antidiuretic hormone effects.

Adverse reactions may occur with oral demeclocycline therapy.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhoea: loose stools, sometimes watery. - Photosensitivity: increased skin reaction to sunlight. - Esophagitis: irritation or ulceration of the oesophagus. - Vestibular disturbances: dizziness or vertigo. - Taste alteration: metallic or altered taste perception.

Serious or Rare Side Effects: - Hepatic toxicity: signs of liver injury such as jaundice. - Severe hypersensitivity: rash, Stevens‑Johnson syndrome or anaphylaxis. - Pseudotumor cerebri: headache with visual disturbances. - Hematologic effects: thrombocytopenia or neutropenia. - Renal impairment: acute interstitial nephritis. - Intracranial hypertension: persistent headache and visual changes.

Before initiating therapy, consider the following safety measures. - Renal function assessment: adjust use in patients with impaired kidney function. - Age restriction: avoid in children younger than eight years due to tooth discoloration risk. - Hepatic monitoring: check liver enzymes periodically in long‑term treatment. - Concomitant calcium or iron supplements: separate dosing to prevent reduced absorption. - Discontinue if severe hypersensitivity occurs: seek immediate medical attention. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Demeclocycline may interact with several drug classes.

Major Interactions (Avoid): - Isotretinoin: combined use increases risk of pseudotumor cerebri. - Anticoagulants (e.g., warfarin): may potentiate anticoagulant effect and bleeding risk. - Other tetracyclines: additive toxicity and reduced efficacy.

Moderate Interactions (Monitor Closely): - Calcium, iron, magnesium supplements: decrease oral absorption of demeclocycline. - Oral contraceptives: may reduce contraceptive effectiveness. - Antacids containing aluminium or magnesium: impair drug absorption.